Replies to post #127668 on Cytodyn Inc (CYDY)

[eklab]

C -20, it depends how long you have been following this stock.

Leronlimab was ready years ago to treat patients without major side effects.

Just lately, after the FDA took over Cytodyns product to keep it out of doctors hands and hospitals, because of its effectiveness, competing with big pharmacies, they found out, that Leronlimab can cure 10 or more diseases without major side effects.

That made it even more valuable with that discovery.

I did not make up this story. proof is available in hospital research trials and also at the FDA itself.